NADAC acquisition cost data for DIGITEK 250 MCG TABLET. This is a generic medication, typically more affordable than brand-name equivalents.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 00378615601 | $0.1930 | 2022-12-21 | Rx |
| 00378615610 | $0.1930 | 2022-12-21 | Rx |
| 42292000201 | $0.1930 | 2022-12-21 | Rx |
| 42292000220 | $0.1930 | 2022-12-21 | Rx |
| 00378615601 | $0.1930 | 2022-12-21 | Rx |
| 00378615610 | $0.1930 | 2022-12-21 | Rx |
| 42292000201 | $0.1930 | 2022-12-21 | Rx |
| 42292000220 | $0.1930 | 2022-12-21 | Rx |
Generic: Digoxin | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $3.5M | 94,486 | 26,098 | $0.7219 |
| 2020 | $2.3M | 65,816 | 26,109 | $0.6951 |
| 2021 | $649.7K | 24,415 | 5,862 | $0.7489 |
| 2022 | $186.0K | 7,142 | 2,685 | $0.7267 |
| 2023 | $789.97 | 23 | 17 | $0.7432 |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.